Literature DB >> 7861412

Polyiodinated triglyceride analogs as potential computed tomography imaging agents for the liver.

J P Weichert1, M A Longino, D A Bakan, M G Spigarelli, T S Chou, S W Schwendner, R E Counsell.   

Abstract

A series of glyceryl 2-oleoyl 1,3-bis[omega-(3-amino-2,4,6-triiodophenyl)] alkanoates was synthesized, radioiodinated with iodine-125, emulsified, and evaluated for their ability to selectively localize in the liver for potential use as hepatographic agents in computed tomography. All seven analogs displayed rapid liver uptake wherein between 65 and 78% of the injected dose accumulated in the liver by 30 min. Liver values ranged from 46 to 93% 3 h after injection which corresponded to liver to blood ratios ranging from 21 to 450. Moreover, subsequent elimination of radioactivity from the liver was nearly linear with respect to alkyl chain length. Analogs with longer alkyl chain length were eliminated from the liver more rapidly than their shorter chain counterparts. Because of their biochemical similarities to naturally occurring triglycerides, these novel analogs may prove useful not only for high-resolution anatomic imaging of focal liver lesions, but also for evaluating a variety of diffuse diseases known to affect hepatic function and biochemistry.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7861412     DOI: 10.1021/jm00004a010

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Time-course of contrast enhancement in spleen and liver with Exia 160, Fenestra LC, and VC.

Authors:  Inneke Willekens; Tony Lahoutte; Nico Buls; Christian Vanhove; Rudi Deklerck; Axel Bossuyt; Johan de Mey
Journal:  Mol Imaging Biol       Date:  2008-12-06       Impact factor: 3.488

Review 2.  Nanotechnology for computed tomography: a real potential recently disclosed.

Authors:  Nicolas Anton; Thierry F Vandamme
Journal:  Pharm Res       Date:  2013-07-30       Impact factor: 4.200

3.  Radiolabeled cholesteryl iopanoate/acetylated low density lipoprotein as a potential probe for visualization of early atherosclerotic lesions in rabbits.

Authors:  W Xiao; L Wang; T Scott; R E Counsell; H Liu
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

Review 4.  Whole animal imaging.

Authors:  Gurpreet Singh Sandhu; Luis Solorio; Ann-Marie Broome; Nicolas Salem; Jeff Kolthammer; Tejas Shah; Chris Flask; Jeffrey L Duerk
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Jul-Aug

5.  MicroCT for high-resolution imaging of ectopic pheochromocytoma tumors in the liver of nude mice.

Authors:  Shoichiro Ohta; Edwin W Lai; John C Morris; Douglas A Bakan; Brenda Klaunberg; Susannah Cleary; James F Powers; Arthur S Tischler; Mones Abu-Asab; Daniel Schimel; Karel Pacak
Journal:  Int J Cancer       Date:  2006-11-01       Impact factor: 7.396

Review 6.  X-ray-computed tomography contrast agents.

Authors:  Hrvoje Lusic; Mark W Grinstaff
Journal:  Chem Rev       Date:  2012-12-05       Impact factor: 60.622

7.  Formulation of polyiodinated triglyceride analogues in a chylomicron remnant-like liver-selective delivery vehicle.

Authors:  M A Longino; D A Bakan; J P Weichert; R E Counsell
Journal:  Pharm Res       Date:  1996-06       Impact factor: 4.200

8.  Noninvasive monitoring of a murine model of metastatic pheochromocytoma: a comparison of contrast-enhanced microCT and nonenhanced MRI.

Authors:  Lucia Martiniova; Melanie S Kotys; David Thomasson; Daniel Schimel; Edwin W Lai; Marcelino Bernardo; Maria J Merino; James F Powers; Jan Ruzicka; Richard Kvetnansky; Peter L Choyke; Karel Pacak
Journal:  J Magn Reson Imaging       Date:  2009-03       Impact factor: 4.813

Review 9.  In vivo micro-CT imaging of liver lesions in small animal models.

Authors:  Lucia Martiniova; Daniel Schimel; Edwin W Lai; Andrea Limpuangthip; Richard Kvetnansky; Karel Pacak
Journal:  Methods       Date:  2009-06-09       Impact factor: 3.608

10.  Micro-CT based experimental liver imaging using a nanoparticulate contrast agent: a longitudinal study in mice.

Authors:  Hanne Boll; Stefanie Nittka; Fabian Doyon; Michael Neumaier; Alexander Marx; Martin Kramer; Christoph Groden; Marc A Brockmann
Journal:  PLoS One       Date:  2011-09-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.